Eledon Pharmaceuticals, Inc.

ELDN - CIK 0001404281

Market cap-

Rank-

SEC filings604

ELDN income statement (quarterly)

The table below shows Eledon Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$17.20M	$14.97M	$20.28M	$13.53M	$16.52M	$10.11M
SG&A

ELDN annual revenue (10-K history)

Eledon Pharmaceuticals, Inc. reported annual revenue of $0.00 for fiscal year 2016. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.